Position in ASND
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$2,717,083
+$903,691 QoQ
Shares Held
11,879
+39.7% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Dorsey Wright & Associates holds $27,982,368 across 7 Biotechnology names. ASND ranks #2 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
577,147 | $15,986,971 | |
| 2 | ASND |
Ascendis Pharma A/S
This page
|
11,879 | $2,717,083 | |
| 3 | ABVX |
Abivax S.A.
|
23,452 | $2,611,380 | |
| 4 | DBVT |
DBV Technologies S.A.
|
102,550 | $2,142,269 | |
| 5 | GMAB |
Genmab A/S
|
64,388 | $1,727,530 | |
| 6 | ARGX |
Argenx SE
|
2,189 | $1,598,517 | |
| 7 | INCY |
Incyte Corp
|
12,735 | $1,198,618 |
All Filings in ASND
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,717,083 | 11,879 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,813,392 | 8,504 | Shares | Sole | 2026-02-20 | |
| 2025-09-30 | $1,638,393 | 8,241 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $1,600,347 | 9,272 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||